DECURA PHARMA

Active Risk: not assessed

Private limited companyfounded 2009active for 17 yearsGistelsesteenweg 18, 8400 Oostende, BelgiumKBO/BCE: BE 0817.127.010

From the official registers: KBO 15 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DECURA PHARMA is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €3.8m and a net result of €271,335. Equity has been growing by about 7.9% per year since 2019. Its solvency ranks better than 37% of 303 sector peers (NACE 64, financial year 2026). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

DECURA PHARMAActive

Risk analysis Report Compare

Official details

KBO

Status: Active since 15-07-2009 Normal situation
Legal form: Private limited company
Registered office: Gistelsesteenweg 18, 8400 Oostende
Activity: Activities of holding companies NACE 64210and 2 others
Establishment units: 2.180.322.745 8400 Oostende, since 26-08-2009
: 2.389.823.444 9030 Gent, since 01-06-2026
Financial year end: 31 March
Peppol: Reachable since 02-09-2023

Company details

Board and ownership

Board

DECUYPERE Andy MichelDirector · since 14-07-2009
RAES Ann Maria BertheDirector · since 14-07-2009

Holdings: Shares in 5 companies including APOTHEEK RAES and HEALTH AND BEAUTY SHOP

Board & ownership

Financial position

Financial institution: outside the modelBankruptcy probability: sector outside the model

Annual accounts to 31-03-2025

Profit: €271,335; ▲ 149%
Equity: €3.8m; ▲ 7.6%
Total assets: €10.9m; ▲ 23.7%

2026 accounts not filed, 1 day past the deadline

Filed on 30-10-2025PDF

Financials

SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model

Model not applicable to financial institutions

The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

1 signal.

neutral

Latest accounts filed on time

The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 30-10-2025, 1 day ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2026

not filed

2025

1 day early

2024

1 day early

2023

1 day early

2022

13 days early

2021

12 days early

2020

13 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 3 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (1)

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Key points

Positive: Result rose in 2025from €108,814 to €271,335 ▲ 149% View
Positive: Higher net result than 95% of companies in financial servicessector median €76,251 · 303 companies €1.6m View
Positive: 7 profitable years in a rowprofit 2025: €271,335 7 years View
Heads a groupcompanies controlled 4 View

Documents

Key facts about DECURA PHARMA

What is the company number of DECURA PHARMA?: The company number of DECURA PHARMA is 0817.127.010. The VAT number is the same number with BE in front: BE 0817.127.010.
Where is DECURA PHARMA based?: The registered office is at Gistelsesteenweg 18, 8400 Oostende.Company details
What does DECURA PHARMA do?: According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of DECURA PHARMA?: The legal form of DECURA PHARMA is Private limited company (BV).
When was DECURA PHARMA founded?: DECURA PHARMA was founded on 15-07-2009.
Is DECURA PHARMA still active?: Yes, DECURA PHARMA is an active enterprise in the KBO register.
How many employees does DECURA PHARMA have?: DECURA PHARMA had an average of 0.1 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
What is the turnover of DECURA PHARMA?: The turnover in financial year 2025 is ≈ €830,000. This figure is estimated from the gross margin of €635,995 and 34 comparable companies (NACE 64210). It probably lies between €700,000 and €1.3m.
Is DECURA PHARMA profitable?: In financial year 2025, DECURA PHARMA made a profit of €271,335.
Where can I find the annual accounts of DECURA PHARMA?: DECURA PHARMA filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)

Companies linked to DECURA PHARMA

Subsidiaries and holdings

Comparable companies

These companies have the same main activity as DECURA PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €6.9m and €17m, founded between 2005 and 2011.

Company	Total assets	Gross margin
DECURA PHARMA Oostende	€12.0m	€2.4m
EMMA Izegem	€11.6m	€2.2m
MAMM-UT INVEST Brussel	€12.1m	€2.2m
LAMI Tongeren-Borgloon	€9.6m	€2.3m
SAPKO Schilde	€12.2m	€2.0m
LIBEL Wevelgem	€16.8m	€2.7m
IMMO CADIX Waregem	€6.9m	€2.7m